Autocrine PDGFR signaling plays an essential role in cancer progression in ovarian (Matei et al., 2006), breast (Jechlinger et al., 2006), thyroid (Adewuyi et al., 2018), and brain (Lokker et al., 2002) cancers. The gene discussed is PDGFRB; the disease is cancer.